Cargando…

Plasma pooling in combination with amotosalen/UVA pathogen inactivation to increase standardisation and safety of therapeutic plasma units

OBJECTIVES: Assessment of the impact of pooling five single‐donor plasma (SDP) units to obtain six pathogen‐reduced therapeutic plasma (PTP) units on standardisation and the retention of labile coagulation factors. BACKGROUND: SDP shows a high inter‐donor variability with potential implications for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bubinski, Michal, Gronowska, Agnieszka, Szykula, Pawel, Kluska, Kamila, Kuleta, Ilona, Ciesielska, Emilia, Picard‐Maureau, Marcus, Lachert, Elzbieta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2021
Materias:	Short Communications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8048654/ https://www.ncbi.nlm.nih.gov/pubmed/33686720 http://dx.doi.org/10.1111/tme.12763

Ejemplares similares

Inactivation of a broad spectrum of viruses and parasites by photochemical treatment of plasma and platelets using amotosalen and ultraviolet A light
por: Lanteri, Marion C., et al.
Publicado: (2020)

Antibody profiles in COVID‐19 convalescent plasma prepared with amotosalen/UVA pathogen reduction treatment
por: Bagri, Anil, et al.
Publicado: (2022)

Inflammatory profile of convalescent plasma to treat COVID: Impact of amotosalen/UVA pathogen reduction technology
por: Cognasse, Fabrice, et al.
Publicado: (2022)

Preparation and Storage of Cryoprecipitate Derived from Amotosalen and UVA-Treated Apheresis Plasma and Assessment of In Vitro Quality Parameters
por: Kovacic Krizanic, Katarina, et al.
Publicado: (2022)

Evaluation of amotosalen and UVA pathogen‐reduced apheresis platelets after 7‐day storage
por: Cancelas, Jose A., et al.
Publicado: (2022)

Protein Concentrations in Stored Pooled Platelet Concentrates Treated with Pathogen Inactivation by Amotosalen Plus Ultraviolet a Illumination
por: Arnason, Niels Arni, et al.
Publicado: (2022)

Profils d’anticorps dans le plasma de convalescent COVID-19 traité pour traitement de réduction des agents pathogènes par Amotosalen/UVA
por: Corash, Laurence, et al.
Publicado: (2021)

Efficient inactivation of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in human apheresis platelet concentrates with amotosalen and ultraviolet A light
por: Hindawi, S.I., et al.
Publicado: (2022)

The neuroprotective activity of heat-treated human platelet lysate biomaterials manufactured from outdated pathogen-reduced (amotosalen/UVA) platelet concentrates
por: Nebie, Ouada, et al.
Publicado: (2019)

Amotosalen and ultraviolet A light treatment efficiently inactivates severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) in human plasma
por: Azhar, Esam I., et al.
Publicado: (2020)

Inactivation of yellow fever virus with amotosalen and ultraviolet A light pathogen‐reduction technology
por: Girard, Yvette A., et al.
Publicado: (2020)

Pathogen inactivation treatment of triple‐dose apheresis platelets with amotosalen and ultraviolet a light
por: Infanti, Laura, et al.
Publicado: (2022)

MANUTENÇÃO DOS NÍVEIS DE ANTICORPOS NEUTRALIZANTES (NAB) E DE LIGAÇÃO PARA PROTEÍNAS DE NUCLEOCAPSÍDEOS (NP) DE SARS-CoV-2 EM UNIDADES DE PLASMA DE DOADORES CONVALESCENTES (CCP) TRATADOS POR AMOTOSALEN/UVA (A/UVA)
por: Wendel, S., et al.
Publicado: (2020)

A prospective, active haemovigilance study with combined cohort analysis of 19 175 transfusions of platelet components prepared with amotosalen–UVA photochemical treatment
por: Knutson, F, et al.
Publicado: (2015)

Clinical impact of amotosalen‐ultraviolet A pathogen‐inactivated platelets stored for up to 7 days
por: Infanti, Laura, et al.
Publicado: (2019)

Assessment of dengue virus inactivation in random donor platelets using amotosalen and ultraviolet A illumination
por: Kumar, Ankit, et al.
Publicado: (2022)

Amotosalen/ultraviolet A pathogen inactivation technology reduces platelet activatability, induces apoptosis and accelerates clearance
por: Stivala, Simona, et al.
Publicado: (2017)

Effectiveness of near-UVA in SARS-CoV-2 inactivation
por: Frilli, Eleonora, et al.
Publicado: (2023)

Inactivation of SARS-CoV-2 in All Blood Components Using Amotosalen/Ultraviolet A Light and Amustaline/Glutathione Pathogen Reduction Technologies
por: Santa Maria, Felicia, et al.
Publicado: (2022)

Fine Particulate Matter-Induced Oxidative Stress Mediated by UVA-Visible Light Leads to Keratinocyte Damage
por: Mokrzyński, Krystian, et al.
Publicado: (2021)

Effects of amotosalen treatment on human platelet lysate bioactivity: A proof-of-concept study
por: Christensen, Christian, et al.
Publicado: (2020)

Standardisation of inactivated influenza vaccines—Learning from history
por: Wood, John M., et al.
Publicado: (2018)

Stability of plasma proteins and factors in Chinese universal pooled plasma
por: Zhu, Liguo, et al.
Publicado: (2018)

Cell type-specific differences in redox regulation and proliferation after low UVA doses
por: Ciesielska, Sylwia, et al.
Publicado: (2019)

Parvovirus B19 DNA and antibodies in Chinese plasma donors, plasma pools and plasma derivatives
por: Sun, Pan, et al.
Publicado: (2023)

Plasma proteins in a standardised skin mini-erosion (II): effects of extraction pressure
por: Svedman, Christer, et al.
Publicado: (2002)

Impact of crosslinking/riboflavin-UVA-photodynamic inactivation on viability, apoptosis and activation of human keratocytes in vitro
por: Stachon, Tanja, et al.
Publicado: (2015)

RND Pump-Mediated Efflux of Amotosalen, a Compound Used in Pathogen Inactivation Technology to Enhance Safety of Blood Transfusion Products, May Compromise Its Gram-Negative Anti-Bacterial Activity
por: Green, Alex B., et al.
Publicado: (2023)

Prevalence of human parvovirus B19 in Chinese plasma pools for manufacturing plasma derivatives
por: Jia, Junting, et al.
Publicado: (2015)

Uvas del mar
por: Martínez, Gastón Alejandro
Publicado: (2022)

Uvas del mar /
por: Martínez, Gastón Alejandro
Publicado: (2022)

The Austrian UVA‐Network
por: Schmalwieser, Alois W., et al.
Publicado: (2019)

Mechanism of Virus Inactivation by Cold Atmospheric-Pressure Plasma and Plasma-Activated Water
por: Guo, Li, et al.
Publicado: (2018)

The complete mitochondrial genome of Cerion uva uva (Gastropoda: Panpulmonata: Stylommatophora: Cerionidae)
por: Harasewych, M. G., et al.
Publicado: (2017)

The Immunogenicity and Properties of a Whole-Cell ETEC Vaccine Inactivated with Psoralen and UVA Light in Comparison to Formalin
por: Westcott, Marlena M., et al.
Publicado: (2023)

Inactivation of Schistosoma Using Low-Temperature Plasma
por: Hejzlarová, Silvie, et al.
Publicado: (2020)

Recent Advances in Prion Inactivation by Plasma Sterilizer
por: Sakudo, Akikazu, et al.
Publicado: (2022)

Cell Cycle Status Influences Resistance to Apoptosis Induced by Oxidative Stress in Human Breast Cancer Cells, Which Is Accompanied by Modulation of Autophagy
por: Kluska, Magdalena, et al.
Publicado: (2023)

Diversity of Biological Effects Induced by Longwave UVA Rays (UVA1) in Reconstructed Skin
por: Marionnet, Claire, et al.
Publicado: (2014)

Plasma proteins in a standardised skin mini-erosion (I): permeability changes as a function of time
por: Svedman, Christer, et al.
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_qggn5hf5h37vm4gdpc7ct6rfdt